SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
Here is the data on what happens to reconstituted retatrutide left at approximately 25 degrees Celsius: Day 1 to 3: Minimal measurable degradation, perhaps 1 to 3 percent potency loss
Association of sweetened carbonated beverage consumption during pregnancy and ADHD symptoms in the offspring: a study from the Norwegian mother, father and child cohort study (MoBa)
This mechanism has positioned Epithalon as a subject of interest in cellular senescence and aging models
In cases specific to weight management in Nederland, Texas, deploying strategic use of FSAs and HSAs can help mitigate medication costs
Because tirzepatide can slow digestion, oral birth control may not work as expected in the weeks following a new prescription or a dose increase